Clinical Trial Update: Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy plus thalidomide in patients with stage IIIB or stage IV non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Combination chemotherapy
• Thalidomide (thalidomide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED